Lv4
770 积分 2025-02-25 加入
Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial
17天前
已完结
Opposing outcomes of short- and long-term epigenetic therapy in breast cancer: Implications for chemotherapy response
1个月前
已完结
An omics-based drug-HIFU combination therapy discovery for ferroptosis treatment of TNBC
1个月前
已完结
Tucidinostat ameliorates DSS-induced ulcerative colitis by inhibiting cellular senescence, modulating the p53 signaling pathway and cell cycle, and restoring the gut microbiota-metabolite Axis
1个月前
已完结
Chemical Perturbations Impacting Histone Acetylation Govern Colorectal Cancer Differentiation
1个月前
已完结
Prognostic factors and clinical outcomes in patients with relapsed acute leukemia after allogeneic hematopoietic stem cell transplantation
1个月前
已完结
INSR/AKT1 axis promotes cells proliferation and migration in acute myeloid leukemia
1个月前
已完结
Cross-resistance of Belinostat and Romidepsin in Non-T Follicular Helper Peripheral T-cell Lymphoma Models Suggests Subtype-Specific Implications for Belinostat-CHOP
1个月前
已完结
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
1个月前
已完结
Nanoromidepsin, a polymer nanoparticle of the HDAC inhibitor, improves safety and efficacy in models of T-cell lymphoma
1个月前
已关闭
皖公网安备34019202002308
